Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster Display session 3

2268 - Classification of abnormal findings on ring-type dedicated breast PET for detecting breast cancer


30 Sep 2019


Poster Display session 3


Staging and Imaging

Tumour Site

Breast Cancer


Shinsuke Sasada


Annals of Oncology (2019) 30 (suppl_5): v574-v584. 10.1093/annonc/mdz257


S. Sasada, N. masumoto, M. Nishina, Y. Kimura, A. Amioka, T. Itagaki, A. Emi, T. Kadoya, M. Okada

Author affiliations

  • Surgical Oncology, Institute of Biomedical & Health Sciences, Hiroshima University, 734-8551 - Hiroshima/JP


Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 2268


Ring-type dedicated breast positron emission tomography (DbPET) can detect small breast cancers; however, there are no category classifications of abnormal findings on DbPET such as BI-RADs (mammography, ultrasonography, and magnetic resonance imaging). We investigated whether the classification of DbPET findings was useful for detecting breast cancer.


A total of 674 patients with breast cancers underwent ring-type DbPET using FDG before treatment between January 2016 and March 2019. Findings were morphologically categorized as a focus (uptake size ≤5 mm), mass (>6 mm), or non-mass (multiple uptakes). Non-mass uptakes were additionally classified based on the distribution: focal, linear, regional, segmental, and diffuse. Maximum standardized uptake value (SUVmax) and tumor-to-normal tissue ratio (TNR) were calculated. The final diagnosis was pathologically evaluated based on biopsy or surgical specimens, and lesions of category 2 or lower by conventional examinations were determined benign.


Among 867 abnormal findings, 668 (77%) were malignant and 199 (23%) were benign. Morphologically, 187 (21.6%) lesions were foci, 413 (47.6%) were masses, and 267 (30.8%) were non-masses. Among non-mass lesions, 131 focal, 1 linear, 15 regional, 115 segmental, and 5 diffuse distributions were presented. The median SUVmax was 5.0 and TNR was 2.8. The area under the curve values of SUVmax and TNR for predicting malignancy were 0.824 and 0.855, respectively. In a multivariate analysis, mass, focal and segmental distributions of non-mass lesions, high TNR were significantly related with breast cancer (all P < 0.001). Pathologically confirmed benign lesions included 45 mastopathies, 29 papillomas, 10 fibroadenomas, 7 ductal adenomas, and 3 others.


Classification using morphological findings and TNRs on DbPET are useful to detect breast cancer. The DbPET classification should be considered for breast cancer screening.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.


Has not received any funding.


All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.